News ArticleMCX Posts 113.9% Revenue Surge to ₹800 Crore and ₹455 Crore PAT in Q2 FY27
Exchange's average daily turnover for futures and options climbs sharply, supported by growth in trading volumes and client base for the half-year ending September 2026
Multi Commodity Exchange of India Limited (MCX) announced unaudited consolidated financial results for Q2 and H1 FY27 with revenues rising above ₹800 crore in Q2 and ₹1,502 crore in H1, driving profits after tax to ₹455 crore in Q2 and ₹868 crore in H1, demonstrating strong year-on-year growth across key metrics including futures and options trading volumes and client participation.
Multi Commodity Exchange of India Limited
General / Other
Multi Commodity Exchange of India Limited (MCX) recorded strong consolidated financial results for the quarter and half-year ended September 30, 2026, with revenue from operations reaching ₹800 crore in Q2 FY27, up 113.9% year-on-year, and profit after tax at ₹455 crore, growing 130.8% year-on-year.
The company's EBITDA for Q2 FY27 increased to ₹664 crore, marking a 145.9% rise year-on-year, with an EBITDA margin expanding to 78.0%. For the half year ending September 2026, MCX reported revenue from operations of ₹1,502 crore and profit after tax of ₹868 crore, reflecting year-on-year growth of 100.8% and 116.4% respectively.
Average daily turnover (ADT) for futures reached ₹62,819 crore in Q2 FY27, a 50.6% increase compared to the same quarter last year, while options ADT surged to ₹12,00,129 crore, up 224.8%. Total futures and options ADT combined was ₹12,62,948 crore, rising over 207% year-on-year in Q2.
Client participation also grew significantly with total traded clients in futures rising to 4.00 lakh and options to 13.03 lakh in Q2 FY27, with half-year totals showing an 89.3% increase year-on-year.
The exchange reported deliveries during Q2 of 5.68 metric tonnes of gold, 199.91 metric tonnes of silver, and 34,707 metric tonnes of base metals, underlining its diverse commodity trading volumes.
Highlights
- Q2 FY27 revenue from operations reached ₹800 crore, 113.9% higher than Q2 FY26.
- Profit after tax in Q2 FY27 stood at ₹455 crore, showing a 130.8% increase year-on-year.
- EBITDA margin expanded to 78.0% in Q2 FY27 from 67.3% in Q2 FY26.
- Average daily turnover of futures increased to ₹62,819 crore in Q2 FY27, up 50.6%.
- Options average daily turnover soared by 224.8% to ₹12,00,129 crore in Q2 FY27.
- Total traded clients in futures and options surged by 89.8% year-on-year in Q2 FY27 to 14.98 lakh clients combined.
Key Data Snapshot
What happened
- MCX's Board approved unaudited consolidated financial results for Q2 and H1 FY27 ending September 30, 2026.
- The exchange achieved revenue from operations of ₹800 crore in Q2 FY27, doubling compared to the same period last year.
- Profit after tax for Q2 FY27 was ₹455 crore, more than doubling year-on-year.
- The half-year revenue stood at ₹1,502 crore with a profit after tax of ₹868 crore.
Key details
- EBITDA for Q2 FY27 rose 145.9% year-on-year to ₹664 crore, with an EBITDA margin increase to 78.0%.
- Average daily turnover (ADT) for futures contracts was ₹62,819 crore in Q2 FY27, up 50.6% from Q2 FY26.
- Options segment ADT reached ₹12,00,129 crore in Q2 FY27, growing by 224.8% year-on-year.
- Total traded clients in futures and options combined increased to 14.98 lakh in Q2 FY27, an 89.8% increase year-on-year.
- Commodity deliveries included 5.68 metric tonnes of gold and 199.91 metric tonnes of silver in Q2 FY27.
Background and context
- MCX is India's leading commodity derivatives exchange and the largest commodity options exchange globally by volume as per FIA 2025 report.
- It holds over 98% market share in traded value of commodity futures contracts in India for H1 FY27.
- MCX offers a platform for trading in bullion, energy, metals, and agricultural commodities, serving a pan-India network.
Highlights
- Q2 FY27 revenue from operations reached ₹800 crore, 113.9% higher than Q2 FY26.
- Profit after tax in Q2 FY27 stood at ₹455 crore, showing a 130.8% increase year-on-year.
- EBITDA margin expanded to 78.0% in Q2 FY27 from 67.3% in Q2 FY26.
- Average daily turnover of futures increased to ₹62,819 crore in Q2 FY27, up 50.6%.
- Options average daily turnover soared by 224.8% to ₹12,00,129 crore in Q2 FY27.
- Total traded clients in futures and options surged by 89.8% year-on-year in Q2 FY27 to 14.98 lakh clients combined.
Disclosures
- Unaudited financial results for Q2 and H1 FY27 approved by Board of Directors
More News on General / Other
View allLatest corporate announcements and market updates in General / Other.
Biocon Limited Reports Q2 FY2027 Profit of Rs. 917 Million and Announces New CTO Appointment
Biocon Limited disclosed its unaudited standalone financial results for the quarter and half year ending September 30, 2026, with a quarterly profit of Rs. 917 million. The board also approved the resignation of CTO Dr. Mandar Shrikant Ghatnekar effective December 31, 2026, and the appointment of Mr. Mukesh Rathi as CTO starting January 1, 2027.
Read Full Story
Biocon Reports Q2 FY27 Total Income of Rs 4,423 Crore With Biopharma Revenue Up 5% and $400 Million Pertuzumab Deal
Biocon Limited announced consolidated total income of Rs 4,423 crore for the second quarter of fiscal year 2027, with biopharma revenues increasing by 5% year-on-year to Rs 3,583 crore. The company's EBITDA was reported at Rs 865 crore and net profit at Rs 41 crore. A significant highlight includes securing a 10-year biosimilar Pertuzumab PDP partnership in Brazil valued at about USD 400 million.
Read Full Story
Zydus Lifesciences Posts Rs. 79,096 Million Revenue in Q2 FY27 with Net Profit at Rs. 9,255 Million
Zydus Lifesciences Limited reported strong revenue growth of 29% year-on-year in Q2 FY27 at Rs. 79,096 million, driven by its branded pharma businesses in India, North America, and international markets. However, net profit declined 27% to Rs. 9,255 million, and EBITDA dropped 6% to Rs. 18,945 million, reflecting cost and margin pressures.
Read Full Story
